NCT05729620View on ClinicalTrials.gov

Evaluation of STARgraft-3 for Hemodialysis

NAActive, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

July 31, 2024

Conditions
End Stage Renal Disease
Interventions
DEVICE

Implant of STARgraft-3 shunt in the upper arm and subsequent use for hemodialysis access

After healing from the surgical procedure, the graft will be routinely cannulated for hemodialysis sessions. Periodic evaluations of blood flow by ultrasound imaging will be made over the study period. Established standards of care will be followed as needed to maintain dialysis function.

Trial Locations (1)

Unknown

Italian Hospital, Asunción

Sponsors
All Listed Sponsors
lead

Healionics Corporation

INDUSTRY